What they are, how they work and why they do what they do? The story of SV40-derived gene therapy vectors and what they have to offer.

Strayer, David S; Cordelier, Pierre; Kondo, Rumi; Liu, Bianling; Matskevich, Alexey A; McKee, Hayley J; Nichols, Carmen N; Mitchell, Christine B; Geverd, Dawn A; White, Martyn K; Strayer, Marlene S

Strayer, David S; Cordelier, Pierre; Kondo, Rumi; Liu, Bianling; Matskevich, Alexey A; McKee, Hayley J; Nichols, Carmen N; Mitchell, Christine B; Geverd, Dawn A; White, Martyn K; Strayer, Marlene S.

Affiliation

Strayer DS; Department of Pathology and Cell Biology, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA. david.strayer@mail.tju.edu

Curr Gene Ther ; 5(2): 151-65, 2005 Apr.

Article in En | MEDLINE | ID: mdl-15853724

Subject(s)

Genetic Therapy; Genetic Vectors; Simian virus 40/genetics; Animals; Humans; Transduction, Genetic; Transgenes; Virus Replication

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Simian virus 40 / Genetic Vectors Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2005 Document type: Article Affiliation country: United States Country of publication: United Arab Emirates

Search on Google

Add to My VHL

XML

PubMed Links